Mixed Phenotype Acute Leukemia (MPAL) Clinical Trials in Morgantown, West Virginia

Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)